Skip to content

A comparative analysis of the mechanisms of resistance to EGFR-TKI in clinical practice: Retrospective study.

A comparative analysis of the mechanisms of resistance to EGFR-TKI in clinical practice: Retrospective study. - Retrospective study of EGFR-TKI in clinical practice.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000030121
Enrollment
2000
Registered
2017-12-01
Start date
2017-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer harboring EGFR mutation.

Interventions

None listed

Sponsors

Aichi Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Non-small cell lung cancer harboring EGFR mutation. (2)Experienced to recieve EGFR tyrosine kinase inhibitor

Exclusion criteria

Exclusion criteria: Nothing

Design outcomes

Primary

MeasureTime frame
Overall survival(restospective research)

Secondary

MeasureTime frame
Progression-free survival(retrospective research) Response rate (retrospective research)

Countries

Japan

Contacts

Public ContactKentaro Ito

Matsusaka Municipal Hospital Respiratory Centor

kentarou_i_0214@yahoo.co.jp+81-598-23-1515

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026